Company valuations


Review our company valuations conducted by external business analytics.


Disclaimer: 

Our analyst partners receives payment from Pharma Equity Group A/S for a Digital IR/Corporate Visibility subscription agreement. 

Stock information

Press on the link button below to be directed to Pharma Equity Groups’ stock information page on Nasdaq.

Notat om skattemæssig anskaffelsessum ved børsnotering

Skattestyrelsen gav den 22. juni 2022 massetilladelse til, at ombytning af aktier i Reponex Pharmaceuticals A/S til aktier i Pharma Equity Group A/S kunne gennemføres som en skattefri aktieombytning. Tilladelsen til skattefri aktieombytning er offentliggjort i SKM2022.324.SKTST, og kan både anvendes af selskabsaktionærer og personlige aktionærer. Download det fulde notat, ved at trykke på knappen nedenstående.

Note on tax basis upon stock exchange listing

The Danish Tax Authority granted a general permit on June 22, 2022, allowing the exchange of shares in Reponex Pharmaceuticals A/S for shares in Pharma Equity Group A/S to be carried out as a tax-free share exchange. The permit for tax-free share exchange has been published in SKM2022.324.SKTST and can be utilized by both corporate shareholders and individual shareholders. Download the complete note by pressing the button below.